CYP2C9/CYP2C19-IN-1
Product Specifications
UNSPSC Description
CYP2C9/CYP2C19-IN-1 (compound 22d) is a potent CYP2C9/CYP2C19 inhibitor, possessing no hepatotoxicity and ames toxicity. CYP2C9/CYP2C19-IN-1 can be used in study of anti-ZIKV[1].
Target Antigen
Cytochrome P450; Virus Protease
Type
Reference compound
Related Pathways
Anti-infection;Metabolic Enzyme/Protease
Applications
COVID-19-anti-virus
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/cyp2c9-cyp2c19-in-1.html
Solubility
10 mM in DMSO
Smiles
COC1=C(C(C)(C)C)C=C(N(C(N2)=O)C=CC2=O)C=C1C3=CC4=CC=C(CCS(=O)(O)=O)C=C4C=C3
Molecular Weight
508.59
References & Citations
[1]Ezeh M I, et al. Chemoinformatic Design and Profiling of Derivatives of Dasabuvir, Efavirenz, and Tipranavir as Potential Inhibitors of Zika Virus RNA-Dependent RNA Polymerase and Methyltransferase. ACS Omega, 2022.
Shipping Conditions
Room temperature
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-151251/CYP2C9-CYP2C19-IN-1-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-151251/
Clinical Information
No Development Reported
CAS Number
3010895-55-0
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
